Table 2. Inclusion criteria and treatment characteristics.

Study	Inclusion criteria	BCG dose (mg)		BCG strain	BCG instillation number
		Low-dose	Standard-dose
Morales et al. [18]	Ta, T1, CIS	60	120	Armand Frappier	6
Yalçinkaya et al. [10]	Ta, T1	54	81	Connaught	6
Kumar et al. [16]	TaG2-3, T1G1-3	40	120	Modified Danish 1331	6
Martínez‐Piñeiro et al. [11]	Recurrent Ta, T1, CIS	27	81	Connaught	12
Irie et al. [14]	Ta, T1	40	80	Tokyo 172	6
Martínez‐Piñeiro et al. [12]	T1G3, CIS	27	81	Connaught	12
Vijjan et al. [17]	Ta or T1 with >G1, size >1 cm, multiple, recurrent	40/80	120	Danish 1331	6
Inamoto et al. [13]	TaG2-3, T1G1-3 with ≤3 cm	40	81	Tokyo 172 (low dose)	6
				Connaught (standard dose)
Yokomizo et al. [15]	CIS, unresectable Ta or T1	40	80	Tokyo 172	8

BCG, bacille Calmette–Guérin.